Compare USAS & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | USAS | OSUR |
|---|---|---|
| Founded | 1998 | 2000 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 254.5M |
| IPO Year | 2004 | 2000 |
| Metric | USAS | OSUR |
|---|---|---|
| Price | $4.41 | $3.85 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $6.50 | $3.00 |
| AVG Volume (30 Days) | ★ 3.5M | 501.8K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $167,064,000.00 |
| Revenue This Year | $174.68 | $4.48 |
| Revenue Next Year | $53.17 | $7.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.52 | $2.08 |
| 52 Week High | $10.50 | $4.58 |
| Indicator | USAS | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 39.58 | 55.40 |
| Support Level | $3.57 | $3.70 |
| Resistance Level | $4.43 | $3.93 |
| Average True Range (ATR) | 0.25 | 0.16 |
| MACD | -0.08 | 0.06 |
| Stochastic Oscillator | 3.68 | 69.74 |
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.